The present invention provides compounds of formula (I) and pharmaceutically acceptable salts, hydrates and solvates thereof for use in the treatment of cancer:
申请公布号
WO2014030001(A1)
申请公布日期
2014.02.27
申请号
WO2013GB52213
申请日期
2013.08.22
申请人
THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL
发明人
JONES, KEITH;CHEESEMAN, MATTHEW DAVID;LINARDOPOULOS, SPYRIDON;FAISAL, AMIR;BARBEAU, OLIVIER REMI;KALUSA, ANDREW
